Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-Treated Patients.

Matthew D Ettleson Wesley H PrietoPedro S T RussoJose de SaWen WanNeda Laiteerapong Rui M B Maciel Antonio Carlos Bianco

Published in: The Journal of clinical endocrinology and metabolism (2022)

In LT4-treated patients, the relationships between serum FT4 vs TSH and FT4 vs T3 across a range of FT4 levels are disproportionate. As a result, dose changes in LT4 that robustly modify serum FT4 and TSH values may only minimally affect serum T3 levels and result in no significant clinical benefit.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes